The p16INK4a transgene dramatically delayed mammary tumorigenesis by ErbB2, indicating that ErbB2-mediated deregulation of cyclin D1/Cdk4/6 is a crucial step of tumor formation. This evidence concerns the gene ERBB2 and neoplasm.